Jobs
>
Cambridge

    Head, Clinical Pharmacology - Cambridge, United States - Leap Therapeutics

    Default job background
    Pharmaceutical / Bio-tech
    Description

    Company Summary

    Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. DKN-01 is being developed in patients with esophagogastric, gynecologic, and colorectal cancers. FL-301, is a humanized monoclonal antibody targeting Claudin18.2, being developed in patients with gastric and pancreatic cancer. Leap also has preclinical antibody programs targeting Claudin18.2/CD137 and GDF15. For more information about Leap Therapeutics, please visit

    General Responsibilities

    The Head of Clinical Pharmacology will be responsible for developing and executing the clinical and non-clinical pharmacology strategies for compounds from the pre-clinical stage through first-in-human and into late-stage clinical development. They will support programs by leading efforts on clinical PK, nonclinical PK, DMPK, ADME, PD and ensuring optimal doses and dosing regimens.

    Specific responsibilities include

    • Work independently, with project teams and vendors to develop and execute clinical pharmacology strategies, including analysis and modeling of PK/PD samples for selection of dose/regimen for drug candidates from preclinical to IND and eventually NDA stage
    • Serve as the subject matter expert on cross-functional teams to lead projects, direct GLP bioanalytical validations and sample analysis across all nonclinical, DMPK and clinical pharmacology development
    • Independently plan and conduct hands-on analyses, including NCA, population PK and PK/PD analyses, exposure-response analyses, clinical trial simulation using a variety of software tools to answer development questions and to inform clinical development strategy
    • Lead method development and qualification of bioanalytical assays via LC-MS/MS and immunoassays and other platforms for clinical biomarker studies
    • Supervise CRO activities to ensure bioanalytical method development/validation activities conducted with CROs lead to robust methods that support bioanalytical analysis
    • Explore new analytical platforms and lead external vendor setup for biomarkers
    • Analyze, interpret and summarize nonclinical and clinical pharmacology data and integrate results into the ongoing clinical development strategy.
    • Contributes to the design of early and late-stage clinical trials (FIH to Submission) including:
    • Non-compartmental analysis for human PK, PD, BM and safety data (including ADA) to guide decision making during dose escalation and dose-response clinical studies
    • Clinical pharmacology and biopharmaceutical aspects for designing key elements trials
    • Write/review/approve relevant sections of clinical study protocols, analysis plans, study reports, and regulatory submissions
    • Develop and maintain collaborative relationship with colleagues within the department, internal stake holders (i.e., Clinical Operations, translational medicine, medical, biometrics, regulatory, CMC, etc.) and external vendors

    Education / Experience / Skills:

    • PhD in pharmacokinetics, clinical pharmacology, pharmacometrics, drug metabolism, pharmacology or related discipline
    • 10+ years of research and development experience with drug metabolism, with demonstrated experience designing, executing and/or managing outsourced clinical pharmacology and nonclinical studies; experience in small – mid size biotech preferred
    • Hands on experience of PK/PD method development and statistical analyses methods used in analyzing clinical data
    • Demonstrated experience in clinical pharmacology and pharmacokinetics and advancing studies through clinical development
    • Excellent leadership and communications skills
    • Experience with managing clinical pharmacology vendors/CROs.
    • Hands-on experience in directing strategy and authoring nonclinical, PK and clinical pharmacology sections of regulatory documents
    • Current knowledge of FDA regulatory guidance related to nonclinical and clinical pharmacology; experience having direct interaction with FDA, including submission of IND, NDA and other regulatory documents

    Leap is an equal opportunity employer and extends equal opportunity to all individuals, without regard to race, color, creed, ancestry, national origin, citizenship, sex or gender (including pregnancy, childbirth, and pregnancy-related conditions), gender identity or expression (including transgender status), sexual orientation, marital status, religion, age, disability, genetic disposition, caregiver status, reproductive health decisions, status as a victim of domestic violence, sexual violence or stalking, credit history, criminal history, service in the military, or any other characteristic protected by applicable federal, state, or local laws and ordinances. We are committed to creating and maintaining a workplace in which all employees have an opportunity to participate and contribute to the success of the business and are valued for their skills, experience, and unique perspectives.



  • Leap Therapeutics Cambridge, United States

    **Head, Clinical Pharmacology**: · **Company Summary**: · **General Responsibilities**: · ***The Head of Clinical Pharmacology will be responsible for developing and executing the clinical and non-clinical pharmacology strategies for compounds from the pre-clinical stage through ...


  • LEAP THERAPEUTICS, INC. Cambridge, United States

    Head, Clinical Pharmacology · Share to LinkedIn Apply Now Apply Now · Company Summary: · Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody target ...


  • Leap Therapeutics Cambridge, United States

    Company Summary · Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. DKN-01 is being developed in patien ...


  • Leap Therapeutics Cambridge, United States

    Company Summary · Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. DKN-01 is being developed in patien ...


  • Leap Therapeutics Cambridge, United States

    Company Summary · Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. DKN-01 is being developed in patien ...


  • AbbVie Cambridge, United States

    Company Description · AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic area ...


  • Leap Therapeutics Cambridge, United States

    Company Summary · Interested in learning more about this job Scroll down and find out what skills, experience and educational qualifications are needed. · Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced ...


  • Takeda Pharmaceuticals Boston, United States

    By clicking the "Apply" button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda's Privacy Notice and Terms of Use . I further attest that all information I sub ...


  • SpringWorks Therapeutics Boston, United States

    Job Description · Job DescriptionAbout SpringWorks Therapeutics: · SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. · SpringWork ...


  • Takeda Boston, MA, United States

    As a trusted global leader and industry partner who is reimagining plasma and exploring its untapped potential, Takeda's Plasma-Derived Therapies (PDT) Business Unit is dedicated to transforming the lives of patients worldwide who rely on these lifesaving and life-sustaining ther ...


  • AstraZeneca, plc Watertown, United States

    Introduction to role:Join us as a Director Clinical Pharmacology & Pharmacometrics, a scientific role that works closely with the clinical team to create a clinical pharmacology development program. This role provides differentiated medicine and the Clinical, Director, Clinic, De ...


  • AstraZeneca Watertown, United States

    Director Clinical Pharmacology & Pharmacometrics (Clinical Pharmacology)Introduction to role:Join us as a Director Clinical Pharmacology & Pharmacometrics, a scientific role that works closely with the clinical team to create a clinical pharmacology development program. This role ...


  • AbbVie Watertown, United States

    Company DescriptionAbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – ...


  • AbbVie Watertown, United States

    Company Description · AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic area ...


  • Bicycle Therapeutics Cambridge, United States

    Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines. Our pipeline includes Bicycle Toxin Conjugates as well as fully synthetic Bicycle systemic immune cell agonists and Bicycle tumor-targeted immune cell agonists ...


  • Bicycle Therapeutics Limited Cambridge, United States

    Company Description · Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines. Our pipeline includes Bicycle Toxin Conjugates as well as fully synthetic Bicycle systemic immune cell agonists and Bicycle tumor-target ...


  • Bicycle Therapeutics Cambridge, United States

    Job Description · Job DescriptionCompany Description · Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines. Our pipeline includes Bicycle Toxin Conjugates as well as fully synthetic Bicycle systemic immune cell a ...


  • Bicycle Therapeutics Limited Cambridge, United States

    Company Description · Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines. Our pipeline includes Bicycle Toxin Conjugates as well as fully synthetic Bicycle systemic immune cell agonists and Bicycle tumor-target ...


  • Jobot Boston, MA, United States

    VP Clinical Pharmacolpgy/DMPK This Jobot Job is hosted by: Audrey Block · Are you a fit? Easy Apply now by clicking the "Apply" button · and sending us your resume. · Salary: $350,000 - $400,000 per year A bit about us: We create new small molecule drugs to combat cancer and ...


  • Jobot Boston, United States

    Job Description · Job DescriptionVP Clinical Pharmacolpgy/DMPK · This Jobot Job is hosted by: Audrey Block · Are you a fit? Easy Apply now by clicking the "Apply Now" buttonand sending us your resume. · Salary: $350,000 - $400,000 per year · A bit about us: · We create new small ...